Serum Proteomic Classifier for patients with advanced NSCLC treated with Erlotinib and bevacizumab in first line

Details

Serval ID
serval:BIB_3FF51EA59128
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Abstract (Abstract): shot summary in a article that contain essentials elements presented during a scientific conference, lecture or from a poster.
Collection
Publications
Institution
Title
Serum Proteomic Classifier for patients with advanced NSCLC treated with Erlotinib and bevacizumab in first line
Title of the conference
ELCC 2012, 3rd European Lung Cancer Conference
Author(s)
Gautschi O., Dingemans A.C.., Crowe S., Roder F., Zappa F., Pless M., Brutsche M., Peters S., Carbone D., Smit E.F.
Address
Geneva, Switzerland, April 18-21, 2012
Publication state
Published
Issued date
2012
Language
english
Create date
21/01/2013 16:40
Last modification date
20/08/2019 14:37
Usage data